Platelet aggregation-IN-2

• UNSPSC Description:

  Platelet aggregation-IN-2 is an anti-platelet aggregation agent with significant anticoagulant activity. Platelet aggregation-IN-2 can inhibit platelet aggregation reaction and reduce the risk of thrombosis. The application of Platelet aggregation-IN-2 can potentially be used for the prevention and suppression of cardiovascular diseases[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/platelet-aggregation-in-2.html

• Smiles:

  O[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(NCCC4=CC=C(C=C4)O)=C3N=C2)O[C@@H]1CO

• Molecular Weight:

  387.39

• References & Citations:

  [1]Platelet aggregation inhibitors. 4. N 6 -substituted adenosines

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  41552-94-7